Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics.
James D ChalmersPierre Regis BurgelCharles L DaleyAnthony De SoyzaCharles S HaworthDavid MaugerKevin MangeAriel TeperCarlos FernandezDan ConroyMark MeterskyPublished in: ERJ open research (2024)
ASPEN baseline characteristics and treatment profiles were representative of a global bronchiectasis population.